The Yersinia pestis virulence effector YopM binds the human pyrin death domain to inhibit inflammasome activation and effector-triggered immunity

This study elucidates the molecular mechanism by which the Yersinia pestis virulence factor YopM binds to the human pyrin death domain to inhibit inflammasome activation, revealing how this specific host-pathogen interaction likely drove the evolutionary selection of Familial Mediterranean Fever-associated mutations.

The Gist

Imagine your body's immune system as a highly trained security team. When a dangerous intruder (like a bacteria) tries to break in, the security team has a "panic button" called the pyrin inflammasome. When pressed, this button sounds the alarm, releases inflammatory chemicals, and even blows a hole in the infected cell to kill the bacteria and stop the spread. It's a drastic but necessary measure to protect the host.

Enter Yersinia pestis, the bacteria that causes the plague. It's a master thief with a high-tech toolkit called a "Type III Secretion System." Think of this as a microscopic syringe that injects special "hacker tools" (proteins) directly into your cells to shut down the security system.

One of these hacker tools is a protein called YopM. Its job is to find the "panic button" (pyrin) and tape it down so it can't be pressed.

This paper is like a detective story where scientists finally figured out exactly how YopM grabs the panic button and why this struggle has shaped human history and disease.

The Detective Work: Finding the Handshake

For a long time, scientists knew YopM stopped the alarm, but they didn't know how it grabbed onto the pyrin protein. It was like knowing a thief had disabled a car alarm, but not knowing which wire they cut.

The researchers used three main tools to solve the mystery:

1. Bacterial Two-Hybrid Assay: A way to see if two proteins want to hold hands.
2. Crystallography: Taking a super-high-resolution 3D "photograph" of the two proteins stuck together.
3. Mutagenesis: Changing the shape of the thief's hand to see if it still fits the lock.

The Big Discovery: The "Velcro" and the "Key"

The scientists discovered that YopM is shaped like a curved horseshoe (a bowl shape). Inside this bowl, there is a sticky, negatively charged surface.

The human "panic button" (pyrin) has a specific part called the PYD (Pyrin Domain) that looks like a key. This key has a very specific shape with a "positive charge" on one side.

The Analogy: Imagine YopM is a magnet with a negative charge, and the human pyrin is a metal key with a positive charge. When the bacteria infects you, YopM swoops in and snaps onto the pyrin key like a magnet. Once it's stuck, it brings in other enzymes (like a "glue gun") to permanently lock the key in the "off" position, preventing the alarm from going off.

The Critical Spot: The "R42" Switch

The researchers found that the most important part of this handshake is a tiny spot on the key called R42.

• In Humans: The key has a specific shape at R42 that fits perfectly into the YopM magnet.
• In Mice: The mouse version of the key has a slightly different shape at that spot. It's like the mouse key is slightly bent. The human magnet (YopM) can't grab the mouse key very well.

This explains a fascinating biological twist: YopM is great at stopping human alarms, but it's not very good at stopping mouse alarms. This suggests that mice and humans have evolved differently in their battle against this specific bacteria.

The "Glue" and the "Glitch"

The scientists made a few tiny changes to the YopM magnet (swapping a few letters in its genetic code).

• When they changed the "glue" spots (specifically residues D159 and D161), the magnet lost its stickiness. It couldn't grab the human key anymore.
• The Result: When the bacteria tried to infect human cells with this "broken" magnet, the alarm went off! The immune system woke up, killed the bacteria, and the infection failed.

This proved that grabbing the key is the only way YopM can stop the alarm. If it can't hold on, the bacteria loses.

Why This Matters for Human History (The "Familial Mediterranean Fever" Connection)

Here is the most exciting part. There is a genetic disease called Familial Mediterranean Fever (FMF). People with FMF have a "hyper-sensitive" alarm system. Their panic buttons are so sensitive that they go off even when there is no intruder, causing fever and pain.

The paper suggests a wild theory: FMF might be an evolutionary superpower.

Thousands of years ago, during the great Plague pandemics, people with a specific mutation in their pyrin gene (specifically at the R42 spot) might have had a key that YopM couldn't grab.

• Normal people: YopM grabs their key, turns off the alarm, and they die of the plague.
• FMF people: YopM tries to grab the key but slips off because the shape is slightly different. The alarm stays on, the immune system fights back, and they survive.

Over centuries, this "broken" key (which causes FMF) became common in Mediterranean populations because it was the only way to survive the plague. It's a classic example of evolutionary arms race: The bacteria evolved a better magnet, and the humans evolved a key that the magnet couldn't stick to.

Summary

• The Villain: Yersinia pestis (Plague bacteria) uses a tool called YopM to disable the body's immune alarm.
• The Mechanism: YopM acts like a magnet, snapping onto a specific part of the immune alarm (pyrin) to shut it down.
• The Weakness: If you change the shape of the magnet's "glue," it can't stick, and the bacteria loses.
• The Legacy: Humans with a specific genetic mutation (FMF) likely survived the Plague because their immune alarms were shaped in a way that the bacteria's tool couldn't disable.

This paper gives us the molecular "blueprint" of how a bacteria disables our immune system and explains why some human genetic diseases might actually be ancient scars from our battle against the Plague.

Technical Summary

1. Problem Statement

Yersinia pestis, the causative agent of plague, utilizes a Type III Secretion System (T3SS) to inject effector proteins into host cells to evade immune detection. Two effectors, YopE and YopT, inactivate host RhoA GTPases, which triggers the assembly of the pyrin inflammasome in phagocytes. This assembly leads to pyroptosis (inflammatory cell death) and the release of pro-inflammatory cytokines (IL-1β, IL-18), a protective immune response.
To counteract this, Y. pestis employs a third effector, YopM, which inhibits the pyrin inflammasome. While it was known that YopM hijacks host kinases (PRK and RSK) to phosphorylate and inactivate pyrin, and that it interacts with the N-terminal region of human pyrin (specifically the Pyrin Domain, or PYD), the molecular mechanism and structural basis of this interaction remained undefined. Furthermore, the evolutionary implications of this interaction regarding the autoinflammatory disease Familial Mediterranean Fever (FMF) were unclear.

2. Methodology

The authors employed a multidisciplinary approach combining structural biology, biochemistry, and cellular infection assays:

• Protein-Protein Interaction Assays:
  • Bacterial Adenylate Cyclase Two-Hybrid (BACTH): Used to screen interactions between YopM isoforms (from Y. pestis strains Pestoides A and KIM) and human (hPYD) vs. murine (mPYD) pyrin domains.
  • GST Pulldown Assays: Used to confirm direct binding between purified GST-tagged YopM and His-tagged PYD fragments.
• Biophysical Characterization:
  • Analytical Size Exclusion Chromatography (SEC) & SEC-MALS: Determined the oligomeric state of YopM in solution (monomer vs. oligomer) at neutral and acidic pH.
  • Velocity Analytical Ultracentrifugation (vAUC): Validated the oligomeric state of YopM.
• Structural Biology (X-ray Crystallography):
  • Co-crystallization of Y. pestis YopM (full-length and a truncated NΔC variant) with human PYD.
  • Data collection at NSLS-II, followed by molecular replacement, refinement, and analysis of electron density maps to determine the binding interface.
• Mutagenesis and Functional Assays:
  • Alanine Substitution: Generated YopM variants (Ala1, Ala2, Ala3) targeting residues predicted to be at the binding interface.
  • Infection Models: Used Y. pseudotuberculosis (lacking native YopM) complemented with wild-type (WT) or mutant YopM variants to infect:
    • THP-1 human monocytes: To assess inhibition of the human pyrin inflammasome (measured by pyrin phosphorylation at S242 and IL-1β release).
    • Murine Bone Marrow Derived Macrophages (BMDMs): To assess inhibition of the mouse pyrin inflammasome.

3. Key Contributions

• Structural Definition: The study provides the first high-resolution co-crystal structures of the Y. pestis YopM effector bound to the human pyrin PYD.
• Mechanistic Insight: It identifies the specific binding interface, revealing that the concave surface of the YopM Leucine-Rich Repeat (LRR) domain binds to the positively charged surface of the human PYD.
• Critical Residues: The study pinpoints specific residues on YopM (D159, D161, F177) and human PYD (R39, R42, S43) that are essential for the interaction.
• Species Specificity: It demonstrates a fundamental difference in how YopM targets human versus murine pyrin, suggesting distinct mechanisms for inflammasome inhibition in different hosts.
• Evolutionary Context: The findings link the molecular mechanism of YopM binding to the evolutionary selection of gain-of-function mutations in the human MEFV gene (causing FMF).

4. Key Results

• Binding Specificity: YopM binds strongly to the human PYD (hPYD) but shows negligible binding to the murine PYD (mPYD) in vitro, despite both species being susceptible to YopM-mediated inflammasome inhibition in vivo.
• Structural Mechanism:
  • The complex forms a 1:1 stoichiometry.
  • The interaction is driven by electrostatic complementarity: the concave surface of YopM is negatively charged, while the hPYD interface (specifically helices $\alpha$2–$\alpha$4) carries a positive charge.
  • Key Interaction: YopM residue D159 forms critical hydrogen bonds and salt bridges with hPYD residue R42 (located in helix $\alpha$3). D161 also forms salt bridges with R39 and R42.
• Functional Validation (Human Cells):
  • YopM variants with alanine substitutions at D159, D161, and F177 (Ala2 variant) lost the ability to bind hPYD in vitro.
  • In THP-1 human monocytes, these binding-defective mutants failed to phosphorylate pyrin at S242 and failed to inhibit IL-1β release, confirming that direct binding to hPYD is essential for inhibiting the human inflammasome.
  • Single mutation D159A had the most severe impact, essentially abolishing function.
• Functional Validation (Mouse Cells):
  • Surprisingly, the same Ala2 variants that failed to bind mPYD in vitro retained the ability to inhibit the pyrin inflammasome in murine macrophages.
  • This suggests YopM uses a distinct, PYD-independent mechanism (likely involving hijacked PRK kinase) to inhibit mouse pyrin, whereas human pyrin inhibition strictly requires direct PYD binding.
• Oligomeric State: YopM exists as a monomer at neutral pH but transitions to an oligomeric state (trimer/tetramer) under mildly acidic conditions.

5. Significance

• Pathogenesis: The study elucidates the precise molecular "lock and key" mechanism Y. pestis uses to disarm the human immune system. By binding the PYD, YopM prevents the recruitment of ASC and subsequent inflammasome assembly.
• Evolutionary Arms Race: The binding site on human PYD (specifically R42) overlaps with sites critical for both positive regulation (ASC binding) and negative regulation (B-box binding). The authors propose that gain-of-function mutations in the MEFV gene (causing Familial Mediterranean Fever), such as R42W, may have been evolutionarily selected during historic plague pandemics. These mutations likely reduce YopM binding affinity, allowing the inflammasome to activate despite the presence of the bacterial effector, thereby providing a survival advantage against plague at the cost of autoinflammation.
• Therapeutic Implications: Understanding the specific residues involved in this interaction provides potential targets for small molecules or peptides that could block YopM-pyrin binding, potentially restoring immune clearance in plague infections.
• Host-Pathogen Specificity: The finding that human and mouse pyrin are inhibited by different mechanisms highlights the limitations of mouse models for studying human-specific aspects of Yersinia pathogenesis and the evolution of human-specific immune defenses.